ONC (STOCKS)
BeOne Medicines Ltd. American Depositary Shares
$305.640000
-4.020000 (-1.30%)
Prev close: $309.660000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- John V. Oyler
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $37,995.19M
- Employees
- 11,000
- P/E (TTM)
- 122.12
- P/B (TTM)
- 7.87
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.28 | $0.63 | -0.3432 | -54.81% |
|
Sep 2025 (Q3)
|
$0.57 | $0.61 | -0.0330 | -5.45% |
|
Jun 2025 (Q2)
|
$0.39 | $0.03 | +0.3597 | +1,187.13% |
|
Dec 2024 (Q4)
|
$22.65 | $1.19 | +21.4592 | +1,800.57% |
Financial Statements
| Revenues | $5.34B |
| Benefits Costs and Expenses | $4.93B |
| Cost Of Revenue | $668.54M |
| Costs And Expenses | $4.23B |
| Gross Profit | $4.67B |
| Operating Expenses | $4.23B |
| Selling, General, and Administrative Expenses | $2.08B |
| Research and Development | $2.15B |
| Operating Income/Loss | $447.14M |
| Income/Loss From Continuing Operations After Tax | $286.93M |
| Income/Loss From Continuing Operations Before Tax | $416.85M |
| Income Tax Expense/Benefit | $129.92M |
| Income Tax Expense/Benefit, Current | $120.45M |
| Income Tax Expense/Benefit, Deferred | $9.47M |
| Net Income/Loss | $286.93M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $286.93M |
| Net Income/Loss Available To Common Stockholders, Basic | $286.93M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.20 |
| Diluted Earnings Per Share | $0.19 |
| Basic Average Shares | 1,417,803,727 |
| Diluted Average Shares | 1,474,829,908 |
| Assets | $8.19B |
| Current Assets | $6.23B |
| Inventory | $608.23M |
| Other Current Assets | $5.63B |
| Noncurrent Assets | $1.95B |
| Fixed Assets | $1.64B |
| Other Non-current Assets | $313.31M |
| Liabilities | $3.83B |
| Current Liabilities | $1.83B |
| Accounts Payable | $479.04M |
| Wages | $305.06M |
| Other Current Liabilities | $1.04B |
| Noncurrent Liabilities | $2.00B |
| Long-term Debt | $836.37M |
| Other Non-current Liabilities | $1.16B |
| Equity | $4.36B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.36B |
| Liabilities And Equity | $8.19B |
| Net Cash Flow From Operating Activities | $1.13B |
| Net Cash Flow From Operating Activities, Continuing | $1.13B |
| Net Cash Flow From Investing Activities | -$276.16M |
| Net Cash Flow From Investing Activities, Continuing | -$276.16M |
| Net Cash Flow From Financing Activities | $1.06B |
| Net Cash Flow From Financing Activities, Continuing | $1.06B |
| Exchange Gains/Losses | $60.02M |
| Net Cash Flow | $1.97B |
| Net Cash Flow, Continuing | $1.91B |
| Comprehensive Income/Loss | $357.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $357.74M |
| Other Comprehensive Income/Loss | $357.74M |
| Other Comprehensive Income/Loss Attributable To Parent | $70.80M |